低比重リポタンパク質検査の世界市場レポート 2025年

低比重リポタンパク質検査市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR5.6％で110億米ドルに成長します。予測期間の成長は、ヘルスケア支出の増加、人口動態の高齢化、心血管疾患負担の増加、個別化医療へのシフト、ヘルスケア政策とガイドラインに起因しています。予測期間の主な動向には、心血管疾患有病率の上昇、予防医療の重視、個別化医療と治療、健康意識と教育の重視、規制ガイドラインと勧告などがあります。

心血管疾患の有病率の増加は、今後数年間の低比重リポ蛋白（LDL）検査市場の成長を促進すると予想されます。心血管疾患は、心臓や血管に影響を及ぼす疾患です。LDL検査は、体内の低比重リポ蛋白のレベルを直接測定することで、心血管疾患を管理するために使用されます。例えば、2024年2月、英国の統治機関である英国議会は、心臓および循環器疾患が英国における全死亡の約25％を占め、年間14万人以上の死者、1日あたり約480人、つまり3分に1人の死亡を引き起こしていると報告しました。その結果、心血管疾患の有病率の増加がLDL検査の需要を押し上げています。

肥満の有病率の増加は、低比重リポタンパク質検査市場の成長を促進すると予想されます。肥満は、過剰な体脂肪蓄積と体格指数（BMI）30以上を特徴とし、多くの健康リスクと関連しています。低比重リポ蛋白（LDL）検査は、肥満に罹患した人のLDLコレステロール値を測定するのに役立ちます。例えば、世界保健機関（WHO）の2022年3月の報告書によると、世界全体で10億人以上が肥満と闘っており、その内訳は成人6億5,000万人、青年3億4,000万人、小児3,900万人で、これらの数は増加傾向にあります。さらに、約1億6,700万人が過体重または肥満のために健康を損なう可能性があると推定されています。したがって、肥満の有病率の増加が低比重リポタンパク質検査市場の成長を促進しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界低比重リポタンパク質検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界の低比重リポタンパク質検査市場：成長率分析
• 世界の低比重リポタンパク質検査市場の実績：規模と成長, 2019-2024
• 世界の低比重リポタンパク質検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界低比重リポタンパク質検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の低比重リポタンパク質検査市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• LDL-C
• LDL-P
• LDL-B
• その他の製品
• 世界の低比重リポタンパク質検査市場：コンポーネント別、実績と予測, 2019-2024, 2024-2029F, 2034F
• キット
• 試薬
• デバイス
• その他のコンポーネント
• 世界の低比重リポタンパク質検査市場：疾患タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 糖尿病
• 脳卒中
• 動脈硬化症
• 肥満
• 脂質異常症
• 頸動脈疾患
• 末梢動脈疾患
• 狭心症
• その他の病気の種類
• 世界の低比重リポタンパク質検査市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 直接入札
• 小売り
• 世界の低比重リポタンパク質検査市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 外来診療
• 調査室
• その他のエンドユーザー
• 世界の低比重リポタンパク質検査市場LDL-C（低密度リポタンパク質コレステロール）の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 直接測定テスト
• 計算されたLDL-C検査
• 世界の低比重リポタンパク質検査市場、LDL-P（低密度リポタンパク質粒子数）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• NMR（核磁気共鳴）検査
• その他の粒子計測方法
• 世界の低比重リポタンパク質検査市場、LDL-B（低密度リポタンパク質粒子サイズ）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• グラジエントゲル電気泳動
• その他のサイズ測定技術
• 世界の低比重リポタンパク質検査市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 脂質パネル検査
• 脂質異常症の遺伝子検査
• ポイントオブケア検査装置

第7章 地域別・国別分析

• 世界の低比重リポタンパク質検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の低比重リポタンパク質検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 低比重リポタンパク質検査市場：競合情勢
• 低比重リポタンパク質検査市場：企業プロファイル
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Qiagen N.V. Overview, Products and Services, Strategy and Financial Analysis
  • Randox Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bio-Rad Laboratories Inc.
• OPKO Health Inc.
• DiaSorin S.p.A.
• Boster Biological Technology Ltd.
• Rockland Immunochemicals Inc.
• Sekisui Diagnostics LLC
• DiaSys Diagnostic Systems GmbH
• Eurolyser Diagnostica GmbH
• Diazyme Laboratories Inc.
• Cell Biolabs Inc
• Home Access Health Corporation
• Thermo Fisher Scientific Inc.
• Becton, Dickinson and Company
• Quest Diagnostics Incorporated
• SpectraCell Laboratories Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 低比重リポタンパク質検査市場2029：新たな機会を提供する国
• 低比重リポタンパク質検査市場2029：新たな機会を提供するセグメント
• 低比重リポタンパク質検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

The low-density lipoprotein (LDL) test is a blood test employed by doctors to measure a patient's levels of LDL cholesterol in the bloodstream. This testing can evaluate LDL levels independently or as part of a lipid panel test, offering insights into the accumulation of cholesterol in the arteries, which can contribute to heart attacks and strokes.

The primary product types of low-density lipoprotein tests include LDL-C, LDL-P, LDL-B, and other related products. Low-density lipoprotein cholesterol (LDL-C), commonly known as 'bad cholesterol,' tends to accumulate in the walls of blood vessels, increasing the risk of health issues such as heart attacks or strokes. The components used in these tests include kits, reagents, devices, and other related components. These tests find applications in various health conditions such as diabetes, stroke, atherosclerosis, obesity, dyslipidemia, carotid artery disease, peripheral arterial disease, angina, among others. Distribution channels encompass direct tenders and retail outlets, with usage prevalent in hospitals, clinics, ambulatory care centers, research laboratories, and other healthcare settings.

The low-density lipoprotein test market research report is one of a series of new reports from The Business Research Company that provides low-density lipoprotein test market statistics, including low-density lipoprotein test industry global market size, regional shares, competitors with a low-density lipoprotein test market share, detailed low-density lipoprotein test market segments, market trends and opportunities, and any further data you may need to thrive in the low-density lipoprotein test industry. This low-density lipoprotein test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The low-density lipoprotein test market size has grown steadily in recent years. It will grow from $8.52 billion in 2024 to $8.85 billion in 2025 at a compound annual growth rate (CAGR) of 3.9%. The growth in the historic period can be attributed to research advancements in cardiovascular medicine, increased awareness of heart health, shift in treatment paradigms, clinical guidelines and recommendations, focus on preventive healthcare.

The low-density lipoprotein test market size is expected to see strong growth in the next few years. It will grow to $11 billion in 2029 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to increasing healthcare expenditure, aging population demographics, rise in cardiovascular disease burden, shift towards personalized medicine, healthcare policy and guidelines. Major trends in the forecast period include rising cardiovascular disease prevalence, emphasis on preventive healthcare, personalized medicine and treatment, focus on health awareness and education, regulatory guidelines and recommendations.

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the low-density lipoprotein (LDL) test market in the coming years. Cardiovascular diseases are conditions that affect the heart or blood vessels. The LDL test is used to manage cardiovascular diseases by directly measuring the levels of low-density lipoprotein in the body. For example, in February 2024, the UK Parliament, the governing body of the UK, reported that heart and circulatory diseases are responsible for around 25% of all deaths in England, causing over 140,000 fatalities annually and approximately 480 deaths per day, or one death every three minutes. As a result, the growing prevalence of cardiovascular diseases is boosting the demand for LDL tests.

The increasing prevalence of obesity is expected to fuel the growth of the low-density lipoprotein test market. Obesity, characterized by excessive body fat accumulation and a body mass index (BMI) of 30 or higher, is associated with numerous health risks. The low-density lipoprotein (LDL) test is instrumental in measuring LDL cholesterol levels in individuals affected by obesity. For instance, according to the World Health Organization's March 2022 report, over 1 billion individuals globally grapple with obesity, comprising 650 million adults, 340 million adolescents, and 39 million children, with these numbers on the rise. Additionally, it is estimated that around 167 million people are poised to experience compromised health due to being overweight or obese. Therefore, the increasing prevalence of obesity is propelling the growth of the low-density lipoprotein test market.

Product innovations are becoming increasingly popular in the low-density lipoprotein (LDL) test market. Leading companies in this sector are launching innovative products to maintain their market positions. For example, in July 2023, Numares Health, a diagnostic company based in Germany, introduced the AXINON LDL-p Test System. This FDA-approved diagnostic tool offers a more comprehensive analysis of lipoproteins, providing insights into cardiac function that go beyond traditional LDL-C measurements. The system uses nuclear magnetic resonance (NMR) spectroscopy and advanced diagnostic algorithms to improve accuracy. It aids physicians in managing patients with a high risk of cardiovascular disease, especially those with cardiometabolic risk factors.

In February 2023, AstraZeneca PLC, a UK-based pharmaceutical and biotechnology company, completed the acquisition of CinCor Pharma Inc. for an undisclosed amount. This strategic move is expected to bolster AstraZeneca's cardiorenal pipeline, expanding it with Baxdrostat, a novel aldosterone synthase inhibitor (ASI). CinCor Pharma Inc., a US-based clinical-last biotechnology company, specializes in developing therapies for lowering LDL hypertension.

Major companies operating in the low-density lipoprotein test market include Abbott Laboratories, Qiagen N.V., Randox Laboratories Ltd., Eurofins Scientific SE, Danaher Corporation, Bio-Rad Laboratories Inc., OPKO Health Inc., DiaSorin S.p.A., Boster Biological Technology Ltd., Rockland Immunochemicals Inc., Sekisui Diagnostics LLC, DiaSys Diagnostic Systems GmbH, Eurolyser Diagnostica GmbH, Diazyme Laboratories Inc., Cell Biolabs Inc, Home Access Health Corporation, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Quest Diagnostics Incorporated, SpectraCell Laboratories Inc., Siemens Healthineers, Laboratory Corporation of America Holdings, Merck KGaA, F Hoffmann-La Roche Ltd., Agilent Technologies Inc., BioVision Incorporated, Abcam plc, BioAssay Systems, BioChain Institute Inc., BioLegend Inc., Enzo Life Sciences Inc., GenScript Biotech Corporation

North America was the largest region in the Low-Density Lipoprotein Test market in 2024. The regions covered in the low-density lipoprotein test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the low-density lipoprotein test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The low-density lipoprotein test market includes revenues earned by entities by measuring very low-density lipoprotein (VLDL) testing and ultra low-density lipoprotein (ULDL) testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Low-Density Lipoprotein Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on low-density lipoprotein test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for low-density lipoprotein test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The low-density lipoprotein test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: LDL-C; LDL-P; LDL-B; Other Products
• 2) By Component: Kits; Reagents; Devices; Other Components
• 3) By Disease Type: Diabetes; Stroke; Atherosclerosis; Obesity; Dyslipidaemia; Carotid Artery Disease; Peripheral Arterial Disease; Angina; Other Disease Types
• 4) By Distribution Channel: Direct Tenders; Retail
• 5) By End User: Hospitals; Clinics; Ambulatory Care; Research Laboratory; Other End Users
• Subsegments:
• 1) By LDL-C (Low-Density Lipoprotein Cholesterol): Direct Measurement Tests; Calculated LDL-C Tests
• 2) By LDL-P (Low-Density Lipoprotein Particle Number): NMR (Nuclear Magnetic Resonance) Tests; Other Particle Counting Methods
• 3) By LDL-B (Low-Density Lipoprotein Particle Size): Gradient Gel Electrophoresis; Other Size Measurement Techniques
• 4) By Other Products; Lipid Panel Tests: Genetic Testing For Dyslipidemia; Point-Of-Care Testing Devices
• Companies Mentioned: Abbott Laboratories; Qiagen N.V.; Randox Laboratories Ltd.; Eurofins Scientific SE; Danaher Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Low-Density Lipoprotein Test Market Characteristics

3. Low-Density Lipoprotein Test Market Trends And Strategies

4. Low-Density Lipoprotein Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Low-Density Lipoprotein Test Growth Analysis And Strategic Analysis Framework

• 5.1. Global Low-Density Lipoprotein Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Low-Density Lipoprotein Test Market Growth Rate Analysis
• 5.4. Global Low-Density Lipoprotein Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Low-Density Lipoprotein Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Low-Density Lipoprotein Test Total Addressable Market (TAM)

6. Low-Density Lipoprotein Test Market Segmentation

• 6.1. Global Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• LDL-C
• LDL-P
• LDL-B
• Other Products
• 6.2. Global Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Kits
• Reagents
• Devices
• Other Components
• 6.3. Global Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diabetes
• Stroke
• Atherosclerosis
• Obesity
• Dyslipidaemia
• Carotid Artery Disease
• Peripheral Arterial Disease
• Angina
• Other Disease Types
• 6.4. Global Low-Density Lipoprotein Test Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Tenders
• Retail
• 6.5. Global Low-Density Lipoprotein Test Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Ambulatory Care
• Research Laboratory
• Other End Users
• 6.6. Global Low-Density Lipoprotein Test Market, Sub-Segmentation Of LDL-C (Low-Density Lipoprotein Cholesterol), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Measurement Tests
• Calculated LDL-C Tests
• 6.7. Global Low-Density Lipoprotein Test Market, Sub-Segmentation Of LDL-P (Low-Density Lipoprotein Particle Number), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• NMR (Nuclear Magnetic Resonance) Tests
• Other Particle Counting Methods
• 6.8. Global Low-Density Lipoprotein Test Market, Sub-Segmentation Of LDL-B (Low-Density Lipoprotein Particle Size), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gradient Gel Electrophoresis
• Other Size Measurement Techniques
• 6.9. Global Low-Density Lipoprotein Test Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lipid Panel Tests
• Genetic Testing For Dyslipidemia
• Point-Of-Care Testing Devices

7. Low-Density Lipoprotein Test Market Regional And Country Analysis

• 7.1. Global Low-Density Lipoprotein Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Low-Density Lipoprotein Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Low-Density Lipoprotein Test Market

• 8.1. Asia-Pacific Low-Density Lipoprotein Test Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Low-Density Lipoprotein Test Market

• 9.1. China Low-Density Lipoprotein Test Market Overview
• 9.2. China Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Low-Density Lipoprotein Test Market

• 10.1. India Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Low-Density Lipoprotein Test Market

• 11.1. Japan Low-Density Lipoprotein Test Market Overview
• 11.2. Japan Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Low-Density Lipoprotein Test Market

• 12.1. Australia Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Low-Density Lipoprotein Test Market

• 13.1. Indonesia Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Low-Density Lipoprotein Test Market

• 14.1. South Korea Low-Density Lipoprotein Test Market Overview
• 14.2. South Korea Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Low-Density Lipoprotein Test Market

• 15.1. Western Europe Low-Density Lipoprotein Test Market Overview
• 15.2. Western Europe Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Low-Density Lipoprotein Test Market

• 16.1. UK Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Low-Density Lipoprotein Test Market

• 17.1. Germany Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Low-Density Lipoprotein Test Market

• 18.1. France Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Low-Density Lipoprotein Test Market

• 19.1. Italy Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Low-Density Lipoprotein Test Market

• 20.1. Spain Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Low-Density Lipoprotein Test Market

• 21.1. Eastern Europe Low-Density Lipoprotein Test Market Overview
• 21.2. Eastern Europe Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Low-Density Lipoprotein Test Market

• 22.1. Russia Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Low-Density Lipoprotein Test Market

• 23.1. North America Low-Density Lipoprotein Test Market Overview
• 23.2. North America Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Low-Density Lipoprotein Test Market

• 24.1. USA Low-Density Lipoprotein Test Market Overview
• 24.2. USA Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Low-Density Lipoprotein Test Market

• 25.1. Canada Low-Density Lipoprotein Test Market Overview
• 25.2. Canada Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Low-Density Lipoprotein Test Market

• 26.1. South America Low-Density Lipoprotein Test Market Overview
• 26.2. South America Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Low-Density Lipoprotein Test Market

• 27.1. Brazil Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Low-Density Lipoprotein Test Market

• 28.1. Middle East Low-Density Lipoprotein Test Market Overview
• 28.2. Middle East Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Low-Density Lipoprotein Test Market

• 29.1. Africa Low-Density Lipoprotein Test Market Overview
• 29.2. Africa Low-Density Lipoprotein Test Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Low-Density Lipoprotein Test Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Low-Density Lipoprotein Test Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Low-Density Lipoprotein Test Market Competitive Landscape And Company Profiles

• 30.1. Low-Density Lipoprotein Test Market Competitive Landscape
• 30.2. Low-Density Lipoprotein Test Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Qiagen N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Randox Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Low-Density Lipoprotein Test Market Other Major And Innovative Companies

• 31.1. Bio-Rad Laboratories Inc.
• 31.2. OPKO Health Inc.
• 31.3. DiaSorin S.p.A.
• 31.4. Boster Biological Technology Ltd.
• 31.5. Rockland Immunochemicals Inc.
• 31.6. Sekisui Diagnostics LLC
• 31.7. DiaSys Diagnostic Systems GmbH
• 31.8. Eurolyser Diagnostica GmbH
• 31.9. Diazyme Laboratories Inc.
• 31.10. Cell Biolabs Inc
• 31.11. Home Access Health Corporation
• 31.12. Thermo Fisher Scientific Inc.
• 31.13. Becton, Dickinson and Company
• 31.14. Quest Diagnostics Incorporated
• 31.15. SpectraCell Laboratories Inc.

32. Global Low-Density Lipoprotein Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Low-Density Lipoprotein Test Market

34. Recent Developments In The Low-Density Lipoprotein Test Market

35. Low-Density Lipoprotein Test Market High Potential Countries, Segments and Strategies

• 35.1 Low-Density Lipoprotein Test Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Low-Density Lipoprotein Test Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Low-Density Lipoprotein Test Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer